American Academy of Family Physicians

Printer-friendly version

Share this page

FDA Fighting for Authority to Regulate Electronic Cigarettes

Appeals Court Order Stays Lower Court Ruling in Favor of e-Cigarette Distributors

By News Staff
3/2/2010

A U.S. Court of Appeals ruling reinstates the FDA's authority -- at least temporarily -- to stop e-cigarettes from entering the country after a lower court ruled that the agency does not have the authority to regulate electronic cigarettes, even though Congress granted the agency the power to regulate tobacco products in 2009.
Stock photo of electronic cigarette
The FDA filed the appeal (15-page PDF; About PDFs) after a U.S. District Court judge granted an injunction (2-page PDF; About PDFs) on Jan. 14 that blocked the FDA from stopping electronic cigarettes from entering the country. The appeals court granted a stay (1-page PDF; About PDFs) of the district court's injunction, pending an appeal. The stay reinstates the FDA's authority.

District Court Judge Richard Leon said in the Jan. 14 ruling that the Family Smoking Prevention and Tobacco Control Act passed last year does give the agency the authority to regulate "any product made or derived from tobacco that is intended for human consumption." That could include e-cigarettes, which contain nicotine extracted from tobacco.

FDA officials, however, say they would prefer to regulate e-cigarettes as drug delivery devices rather than as tobacco products because treating e-cigarettes as the former would give the agency far broader control, including the ability to block importation of the devices and their components.

The agency said in its appeal that it has regulated nicotine products, including nicotine patches, for years under the drug and device provisions of the Food, Drug and Cosmetic Act, or FDCA. The agency argued that tobacco legislation enacted last year "expressly excludes from the definition of 'tobacco product' any article that is a drug, device or combination product under the FDCA, and provides that such articles shall be subject to regulation under the pre-existing FDCA provisions."

An agency spokesperson declined to comment on the case, which is ongoing.

According to court records, the dispute between the FDA and e-cigarette distributors started in September 2008 -- before the tobacco legislation passed -- when the agency put a hold on two shipments of e-cigarettes at Los Angeles International Airport. A month later, FDA officials issued notices of detention on the grounds that shipments belonging to Smoking Everywhere Inc. -- one of the companies that later sued the FDA -- appeared to be "adulterated, misbranded or otherwise in violation" of the FDCA.

In July 2009, the FDA issued a warning about e-cigarettes to consumers and physicians after the Division of Pharmaceutical Analysis in the agency's Center for Drug Evaluation and Research said samples from the products had detectable levels of known carcinogens and toxic chemicals.

Manufacturers have touted the smokeless products, which are battery-operated devices that turn nicotine and other chemicals into a vapor that is inhaled by the user, as safer than conventional cigarettes. However, public health officials have countered that the products have not been adequately tested and should not be marketed to young people.


Health of the Public

Misuse of Fingerstick, Similar Devices Linked to Bloodborne Infections

HHS Expands Medicare Coverage of Tobacco Cessation Counseling

More Than 500 Million Eggs Recalled as Investigation Continues

AAFP Joins Court Brief Supporting Vaccine Injury Compensation Program

GAO Report Critical of Genetic Tests Marketed to Consumers

Advisory Panel Rejects FDA Plan for Controlling Opioid Use

FDA Warns Docs, Patients About Unapproved IUDs

Studies Link Vitamin D, Cognitive Ability in Seniors

NFID Initiative Aims to S.T.O.P. Meningitis!

FDA Expert Panel Members Split on Avandia Question

FDA Adds to Leflunomide's Boxed Warning

McNeil Expands Recall List Again

FDA Warns Against Off-Label Use of Malaria Drug

Dietary Guidelines Report Focuses on Obesity

Pertussis Activity Spikes in Several States

AAFP Wants Medicaid Coverage for Quitlines

HHS Launches Multifaceted Health Literacy Plan

FDA to Report on Safety Monitoring Activities

AAFP Recruiting Practices for Smoking Cessation Pilot

Hypertension Well-controlled in Half of U.S. Adults

AMA Delegates Tackle Various Public Health Issues

CDC: One in Five Teens Has Abused Prescription Meds

Report: FDA Needs Overhaul of Food Safety System

IOM Calls for More Scrutiny of Food, Supplement Health Claims

FDA Proposals Would Shed Light on Drug Approval Process

IV Antibiotics, Antiemetic Recalled After Mold Detected

More Children's Medications From Shuttered McNeil Plant Recalled

Severe Liver Injury Tied to Orlistat Prompts Label Revisions

AAFP, Others Urge Ratification of Tobacco Treaty

AAFP Defends USPSTF, Breast Cancer Screening Recs

FDA Investigating McNeil Consumer Healthcare

Encouraging Healthy Lifestyles: A Special Report on Overweight and Obesity

FDA Campaign Cracks Down on Misleading Drug Ads

FDA Forces Device Maker to Recall Infusion Pumps

McNeil Recalls Multiple OTC Infants', Children's Products

FDA Conducting Safety Review of Prostate Cancer Drugs

FDA Offers Guidance on Rosiglitazone Use as Safety Review Continues

First Lady Launches Campaign to Fight Childhood Obesity

Surgeon General Offers Vision for Healthy, Fit Nation